Prof. (Dr) Kalicharan Sharma | Faculty Pharmacy

Prof. (Dr) Kalicharan Sharma
Professor and Dean

Dr. Kalicharan Sharma is a distinguished medicinal chemist with a PhD in Pharmaceutical Chemistry from Jamia Hamdard University, specializing in drug design, molecular modelling, and synthetic chemistry, with impactful contributions to cancer, inflammatory, infectious diseases, and COVID-19 research. His career spans academia–industry collaborations at Piramal Discovery Solutions, Mankind Research Centre, and Remedium Therapeutics, highlighted by the successful design and clinical translation of Coroquil-Zn during the COVID-19 pandemic. He has supervised over 35 M. Pharm students and 1 PhD awarded, is mentoring 6 PhD scholars, with more than 115 publications, 7 patents, 10 book chapters and 2 Books. His work has earned national awards and fellowships, and he actively consults for pharmaceutical companies, bridging computational design with real-world therapeutic solutions of healthcare. 

RESEARCH DETAILS

ORCID iD: https://orcid.org/0000-0003-0333-2521

Scopus Author ID: 57202130288

Vidwan ID: N/A

Google Scholar Profile: https://scholar.google.co.in/citations?hl=en&user=1uL2tAgAAAAJ&view_op=list_works&sortby=pubdate

 

LIST OF RESEARCH PUBLICATION: 

• Saha, A.; Sharma, K. Electrochemical biosensor-based strategies for sensitive detection of prostate cancer biomarkers. Clinica Chimica Acta 2026, 591, 121140. DOI: https://doi.org/10.1016/j.cca.2026.121140. IF: 2.9 

• Nag, S.; Thakur, D.; Sharma, K. Indole-based kinase modulators for NSCLC: recent advances in synthetic route, SAR and molecular docking studies. Future Medicinal Chemistry 2026, 1-17. DOI: 10.1080/17568919.2026.2688859. IF: 3.4 

• Chakraborty, S.; Nandi, A.; Sahu, G. P.; Saha, A.; Sharma, K. Expansion from conventional analytical methods to smart sensors: advances in detecting organic and inorganic pollutants. Environmental Technology Reviews 2026, 15 (1), 290-316. DOI: 10.1080/21622515.2026.2669115. IF: 0.0 

• Sharma, K.; Thakur, D.; Shinde, S. S.; Sharma, A.; Ghosh, M. Identification of a cyclized urea-based benzothiazole scaffold as an acetylcholinesterase inhibitor. In Silico Research in Biomedicine 2026, 2, 100377. DOI: https://doi.org/10.1016/j.insi.2026.100377. IF: 00 

• Sharma, M.; Gandhi, A.; Sharma, K. Triazole-based inhibitors for breast cancer: biological activity, SAR and synthetic strategies. Molecular Diversity 2026. DOI: 10.1007/s11030-026-11583-6. IF: 4.0 

• Majhi, P.; Pal, V.; Sharma, K.; Bharadwaj, A.; Brar, S. The genus Amaranthus: An updated systematic literature review on its phytochemistry and pharmacological insights. Pharmacological Research – Natural Products 2026, 11, 100763. DOI: https://doi.org/10.1016/j.prenap.2026.100763. IF: 0.8 

• Nandi, A.; Turkar, M. K.; Asthana, S.; Lather, A.; Sharma, K. Computational modeling of the DprE1 and DprE2 protein interface for antitubercular drug discovery. Discover Chemistry 2026, 3 (1), 253. DOI: 10.1007/s44371-026-00708-3. IF: 00 

• Akhter, G.; Beg, M. A.; Rehman, S. u.; Selvapandiyan, A.; Sharma, K.; Dhawan, B.; Sarfaraz, M.; Alam, M. S.; Tantray, M. A.; Hamid, H. The design and synthesis of cysteine protease inhibitors containing isoxazole bearing warheads against Leishmania donovani. Naunyn-Schmiedeberg’s Archives of Pharmacology 2026. DOI: 10.1007/s00210-026-05323-8. IF: 3.5 

• Gaur, Y. K.; Turkar, M. K.; Nandi, A.; Thakur, D.; Chawla, P. A.; Akhter, M.; Tanwar, O.; Sharma, K. Identification of Selective Mtb-DHFR Inhibitors as Antitubercular Agents: A Fragment Merging Approach. Curr Comput Aided Drug Des 2026. DOI: 10.2174/0115734099420676260218064046  From NLM. IF: 1.9 

• Pal, V.; Sharma, S.; Bharadwaj, A.; Singh, R.; Negi, S.; Sharma, K.; Das Gupta, G. Phytochemistry and pharmacological activities of Tadehagi triquetrum (L.) H. Ohashi, an Asian medicinal plant: a comprehensive review. Phytochemistry Reviews 2026. DOI: 10.1007/s11101-026-10227-9. IF: 9.0 

• Sharma, K.; Thakur, D.; Turkar, M.; Alam, M. M.; Shaquiquzzaman, M.; Akhter, M. Identification of Novel Leads as Antitubercular Agents that Target Mtb-DHFR by using Virtual Screening. Curr Med Chem 2026. DOI: 10.2174/0109298673384603250812175443 PubMed. IF: 3.1 

• Sahu, G. P.; Nandi, A.; Saha, A.; Chakraborty, S.; Ganti, S. S.; Sharma, K. Expansion of CKD diagnostics through biosensor technology: An early detection approach. Clinica Chimica Acta 2026, 583, 120833. DOI: https://doi.org/10.1016/j.cca.2026.120833. IF: 2.9 

• Dahiya, R.; Goyal, K.; Sharma, K.; Rawat, A.; Sharma, V.; Mathur, P. Scorpion venom as a molecular treasure: emerging bioactive compounds and translational therapeutic insights. Archives of Toxicology 2025. DOI: 10.1007/s00204-025-04251-5. IF: 6 

• Pandurang, G.A., et al., Discovery of potent DprE1-targeted antitubercular agents: synthesis and evaluation of PBTZ169/TBA7371-based derivatives. Molecular Diversity, 2025. IF: 4 

• Dandamudi, E.G., et al., Performance of transformer-convolutional neural network ensemble for melanoma diagnosis on segmented 3D total body photography data: Cross-Validation stratified K-fold. Biosensors and Bioelectronics: X, 2025. 27: p. 100714. IF: 10.8 

• Kajal, Z., et al., Effects of Catalysts, Solvents, and Temperature on Nenitzescu Reaction. Current Organic Chemistry, 2026. 30(6): p. 441-453. IF: 1.7 

• Kumari, A., et al., Exploring the phytochemistry and therapeutic potential of Chenopodium album l: A land to lab concept. Next Research, 2026. 4: p. 101253. IF: 00 

• Prabhnain, K., et al., Mitigating Diabetic Cardiomyopathy: The Therapeutic Potential of a Poly Herbal Combination in Modulating ICAM-1, VCAM-1, and NF -κB Expression in Rat Model. Cardiovascular & Hematological Disorders-Drug Targets, 2025. 25(4): p. 254-266. IF: 1 

• Mansi, S., et al., Recent Progression and Treatment Approaches of Kidney Fibrosis: Evidence to Clinic Approach. Endocrine, Metabolic & Immune Disorders – Drug Targets, 2025. 25: p. 1-14. IF: 1.7 

• Kaur, P., et al., Unveiling VCAM-1’s Multifaceted Role in Secondary Diabetic Complications. Journal of Food Quality, 2025. 2025(1): p. 9206712. IF: 3 

• Thakur, D., et al., Updated insights on ASK1 signaling: mechanisms, regulation, and therapeutic potential in diseases. Molecular and Cellular Biochemistry, 2025. 480(10): p. 5267-5296. IF: 4 

• Nandi, A.; Gaur, Y. K.; Thakur, D.; Daweshar, E.; Sharma, K. Design and fabrication of smartphone based single paper lateral flow assay for early detection of PCOS biomarker. Biosensors and Bioelectronics: X 2025, 26, 100672. DOI: https://doi.org/10.1016/j.biosx.2025.100672. IF: 10.8 

• Zayed, A.; Sayah, K.; Sharma, K.; Radwan, R. A.; Ezzat, S. M. β-Galactosidase inhibition explored by biochemical methods and in silico studies for plant polyphenols. Archives of Biochemistry and Biophysics 2025, 772, 110568. DOI: https://doi.org/10.1016/j.abb.2025.110568. IF: 3.3 

• Nandi, A.; Gillespie, S. W.; Ice, S. N.; Thakur, D.; Gaur, Y. K.; Singh, K.; Sharma, K. Electrochemical immunosensors targeting hormonal biomarkers for polycystic ovary syndrome: Recent advances and analytical bottlenecks. Biosensors and Bioelectronics: X 2025, 26, 100657. DOI: https://doi.org/10.1016/j.biosx.2025.100657. IF: 10.8 

• Yasmin, A.; Passi, A.; Jha, R.; Saha, P.; Sharma, K.; Jindal, S.; Goyal, K. Benzopyran Derivatives as Emerging Anticancer Agents: Advances in Synthesis, SAR Insights, and Therapeutic Potential. ChemistrySelect 2025, 10 (35), e02424. DOI: https://doi.org/10.1002/slct.202502424. IF: 2.1 

• Nandi, A.; Singh, K.; Sharma, K. Advancement in early diagnosis of polycystic ovary syndrome: biomarker-driven innovative diagnostic sensor. Microchimica Acta 2025, 192 (5), 331. DOI: 10.1007/s00604-025-07187-w. IF: 5.55 

• Sanchit, A.; Ashwani, S.; Ramsha, I.; Dalapathi, G.; Kalicharan, S.; Divya, J.; Kuldeep, S. Recent Outbreaks and Factsheet of Future Global Pandemic Marburg Virus: A Looming Threat. Anti-Infective Agents 2025, 23 (4), 1-17. DOI: http://dx.doi.org/10.2174/0122113525341920241015041123. IF: 1.10 

• Mukesh, K.; Aniket, N.; Ramji Lal, Y.; Ghanshyam Das, G.; Kalicharan, S. AI-Enhanced Prediction Tools and Sensor Integration in Advanced Analytical Chemistry Techniques. Current Analytical Chemistry 2025, 21, 1-21. DOI: http://dx.doi.org/10.2174/0115734110373957250516113853. IF: 1.55 

• Aboti, J.; Parvez, M.; Zuhaid, M.; Sharma, S.; Basit, R.; Kour, M.; Sharma, K.; Singh, S. K.; Chashoo, G.; Haneef, J.; et al. Synthesis of benzenesulfonamide tethered pyrazolyl stilbene derivatives: Their anti-proliferative and carbonic anhydrase inhibitory potentials. Bioorganic Chemistry 2025, 163, 108662. DOI: https://doi.org/10.1016/j.bioorg.2025.108662. IF: 4.5 

• Priyanka, S.; Kalicharan, S.; Anoop, K.; Mukesh, N. In Silico Exploration of Ayurvedic Extract for Targeting Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Via GPR120 and GPR40. Current Diabetes Reviews 2025, 21, 1-13. DOI: http://dx.doi.org/10.2174/0115733998380420250411073427. IF: 2.5 

• Gaur, Y. K.; Akhter, M.; Nandi, A.; Thakur, D.; Gonchi, N.; Gunjal, A. P.; Sharma, K. DprE1 Inhibitors in Clinical Trials: A Route Scouting Approach. ChemistrySelect 2025, 10 (23), e01447. DOI: https://doi.org/10.1002/slct.202501447. IF: 2.3 

• Mansi, S.; Mansi, k.; Pranjal, K.; Ghanshyam Das, G.; Kalicharan, S. Recent Progression and Treatment Approaches of Kidney Fibrosis: Evidence to Clinic Approach. Endocrine, Metabolic & Immune Disorders – Drug Targets 2025, 25, 1-14. DOI: http://dx.doi.org/10.2174/0118715303374764250612052832. IF: 1.5 

• S. Kritika, N. Riya, P. Lakshita, M. Mahima, S. Ajay, Y. Ramji Lal, G. Ghanshyam das, S. Kalicharan, Recent Progression and Treatment Approaches for the Kidney Stone Management, Current Drug Targets 26 (2025) 1-22. IF: 3.0 

• S. Kumari, M. Akhter, G.D. Gupta, K. Sharma, Progression and expansion of ALK inhibitors against NSCLC: A dual target approach, European Journal of Medicinal Chemistry 293 (2025) 117722. IF: 6.7 

• A. Nandi, K. Singh, K. Sharma, Advancement in early diagnosis of polycystic ovary syndrome: biomarker-driven innovative diagnostic sensor, Microchimica Acta 192(5) (2025) 331. IF: 5.4 

• V. Sharma, J. Reang, V. Yadav, P.C. Sharma, J. Majeed, K. Sharma, Discovery of 6-amino pyridine clubbed heterocycles as potent dual GSK-3β/CK-1δ inhibitors for the treatment of Alzheimer’s disease, Bioorganic Chemistry 159 (2025) 108409. IF: 4.5 

• S.K. Rai, R.I. Patil, K. Sharma, I. Khan, A. Panwar, R. Kumar, A. Kumar, Identification and evaluation of cyclic urea based 4H-triazolo pyridine substituted derivatives as novel ASK1 inhibitors, Bioorganic Chemistry 159 (2025) 108375. IF: 4.5 

• Sharma, S.; Beg, M. A.; Latief, I.; Aboti, J.; Jamal, S.; Juneja, P.; Tanwar, S.; Sharma, K.; Rehman, S. u.; Selvapandiyan, A.; et al. Design, synthesis and biological activity of peptidyl β-nitrostyrenes as cysteine protease inhibitors against Leishmania donovani. RSC Advances 2025, 15 (8), 5703-5719. IF: 4.0 

• Aniket, S.; Aniket, N.; Ghanshyam Das, G.; Ajay, S.; Kalicharan, S. Green Synthesis of Curcumin Loaded Carbon Dots as a Sustained Drug Delivery for Anticancer Therapy. Current Pharmaceutical Design 2025, 31, 1-8. IF: 3.0 

• Rabin, D.; Kalicharan, S. Design, Synthesis, and Biological Evaluation of Triazine-4-Thiazolidinone Hybrid Molecules as Modulator of Breast Cancer. Current Enzyme Inhibition 2025, 21, 1-15. IF: 0.5 

• Amit, L.; Pratibha, R.; Manish Kumar, G.; Kalicharan, S.; Tanuj, H. In silico based Diabetic Wound Healer from Nature: An Update. Current Drug Discovery Technologies 2025, 22, 1-14. IF: 0.5 

• Ritu; Prabhnain, K.; Kanika, G.; Ramesh, K. G.; Ayushi, S.; Kalicharan, S. Uncovering the Impact of MMP-9 and TIMPs in Diabetic Nephropathy: A Review on Bioflavonoids in Disease Management. Current Nutraceuticals 2025, 6, 1-16. IF: 0.5 

• Akhter, G.; Hamid, H.; Dhawan, B.; Kumar Das, A.; Tantray, M. A.; Alam, M. S.; Sharma, K. Synthesis and Design of New 1,3,4-Oxadiazole Benzimidazole Hybrids as Potential Antibacterial Agents Against MRSA by Targeting FabI. ChemistrySelect 2024, 9 (48), e202404473. IF: 2.0 

• Sonawane, N. G.; Thakur, A.; Pillai, A. K. S.; Sharma, A.; Gunjal, A. P.; Sharma, K. Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular Agents. Chemical Biology & Drug Design 2024, 104 (6), e70027. IF: 3.0 

• Arzoo, P.; Ramesh, K. G.; Kalicharan, S. The Potential Role of Herbal Plants in the Management of Depression: Pre-Clinical and Clinical Evidence. Current Nutraceuticals 2025, 6, 1-25. IF:1.0 

• Arun, K. M.; Kamal, Y. T.; Mhaveer, S.; Gulam, R.; Arvind, K.; Harpreet, S.; Kalicharan, S.; Amrita, M. <i>In-silico</i> based Designing of benzo<i>[d]</i>thiazol-2-amine Derivatives as Analgesic and Anti-inflammatory Agents. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2024, 23 (4), 230-260. IF:0.5 

• Arzoo, P.; Ramesh, K. G.; Kalicharan, S. The Efficacy of Bibliotherapy in Depression Management: A Systematic Review of Randomized Clinical Trials. Current Psychiatry Research and Reviews 2024, 20, 1-14. IF:1.0 

• Samoon, R.; Sau, S.; Roy, A.; Parida, K. K.; Sharma, K.; Yakkala, P. A.; Dewangan, R. P.; Abdin, M. Z.; Kalia, N. P.; Shafi, S., Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents. ACS Infectious Diseases 2024. IF:4.0 

• Devnath, R.; Sharma, K., Government’s bold initiatives: tackling cervical cancer in India with determination and commitment. Current Medical Research and Opinion, 1-3. IF:2.5 

• Sharma, A.; Singh, A.; Debnath, R.; Gupta, G. D.; Sharma, K., Role of O-GlcNAcylation in Alzheimer’s disease: Insights and perspectives. European journal of medicinal chemistry reports 2024, 12, 100195. IF:4.0 

• Basheer, H.; Shamsi, S.; Qadir, A.; Sharma, K.; Azad, C. S.; Kumar, A.; Khan, I. A., Kanamycin−Cu(II) Complex Catalyzed Ullmann Amine Synthesis at Room Temperature: A Tool for Mechanistic Insights into Methylene Blue Degradation. European Journal of Organic Chemistry 2024, 27 (29), e202400328. IF:3.2 

• Ramzan, F.; Nabi, S. A.; Lone, M. S.; Bonardi, A.; Hamid, A.; Bano, S.; Sharma, K.; Shafi, S.; Samim, M.; Javed, K.; Supuran, C. T., Synthesis, biological evaluation and theoretical studies of (E)-1-(4-sulfamoyl-phenylethyl)-3-arylidene-5-aryl-1H-pyrrol-2(3H)-ones as human carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2023, 38 (1), 2189126. IF:5.1 

• Kaur, A.; Sharma, K.; Sharma, N.; Aggarwal, G., An Insight into the Repurposing of Phytoconstituents obtained from Delhi’s Aravalli Biodiversity Park as Antifungal Agents. Infect Disord Drug Targets 2024. IF:2.50 

• Karande, S.; Das, B.; Acharya, S. S.; Kumar, A.; Patel, H.; Sharma, A.; Gupta, M.; Ahmad, I.; Bhandare, V.; Sharma, K.; Kundu, C. N.; Patil, C., Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents. Journal of Biomolecular Structure and Dynamics, 1-13. IF:4.50 

• Yadav, V.; Reang, J.; Vinita; Sharma, P. C.; Sharma, K.; Kumar, D.; Tonk, R. K., Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment. European journal of medicinal chemistry reports 2024, 10, 100142. IF:4.0 

• Sharma, V.; Chander Sharma, P.; Reang, J.; Yadav, V.; Kumar Tonk, R.; Majeed, J.; Sharma, K., Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach. Bioorganic Chemistry 2024, 147, 107378. IF:5.3 

• Kaur, P.; Dahiya, R.; Nandave, M.; Sharma, K.; Goyal, R. K., Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications. Cell Biochemistry and Function 2024, 42 (4), e4037. IF:3.65 

• Kaur, P.; Sharma, K.; Goyal, R. K., Moringa oleifera extract ameliorates diabetic retinopathy via NF-κB and VCAM-1 pathway in streptozotocin induced diabetic rats. South African Journal of Botany 2023, 162, 519-530. IF:3.20 

• Yadav, N.; Mudgal, D.; Mishra, S.; Sehrawat, H.; Singh, N. K.; Sharma, K.; Sharma, P. C.; Singh, J.; Mishra, V., Development of ionic liquid-capped carbon dots derived from Tecoma stans (L.) Juss. ex Kunth: Combatting bacterial pathogens in diabetic foot ulcer pus swabs, targeting both standard and multi-drug resistant strains. South African Journal of Botany 2023, 163, 412-426. IF:3.20 

• Sharma, S.; Anjaneyulu Yakkala, P.; Beg, M. A.; Tanwar, S.; Latief, I.; Khan, A.; Sharma, K.; ur Rehman, S.; Selvapandiyan, A.; Shafi, S., 5-Arylidene-2,4-thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani. ChemistrySelect 2023, 8 (29), e202302415. IF: 2.307 

• Nabi, S. A.; Ramzan, F.; Lone, M. S.; Nainwal, L. M.; Hamid, A.; Batool, F.; Husain, M.; Samim, M.; Shafi, S.; Sharma, K.; Bano, S.; Javed, K., Halogen substituted aurones as potential apoptotic agents: synthesis, anticancer evaluation, molecular docking, ADMET and DFT study. Journal of Biomolecular Structure and Dynamics 2023, 1-18. IF: 5.23 

• Byareddy, S. N.; Sharma, K.; Sachdev, S.; Reddy, A. S.; Acharya, A.; Klaustermeier, K. M.; Lorson, C. L.; Singh, K., Potential therapeutic targets for Mpox: the evidence to date. Expert Opinion on Therapeutic Targets 2023. IF: 6.79 

• Agarwal, U.; Tonk, K. R.; Sharma, K.; Bhutani, R.; Verma, S., Synthesis, ADME, Molecular Docking and Biological Evaluation of New 2- Aminobenzothiazloes. Current Bioactive Compounds 2023, 19, 1-14. IF:0.21 

• Sharma, S.; Iqubal, A.; Khan, V.; Sharma, K.; Najmi, A. K.; Haque, S. E., Icariin ameliorates oxidative stress-induced inflammation, apoptosis, and heart failure in isoproterenol-challenged Wistar rats. Iranian journal of basic medical sciences 2023, 26 (5), 517-525. IF: 2.69 

• Ramzan, F.; Nabi, S. A.; Lone, M. S.; Bonardi, A.; Hamid, A.; Bano, S.; Sharma, K.; Shafi, S.; Samim, M.; Javed, K.; Supran, C. T., Synthesis, biological evaluation and theoretical studies of (E)-1-(4-sulfamoyl-phenylethyl)-3-arylidene-5-aryl-1H-pyrrol-2(3H)-ones as human carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2023, 38 (1), 2189126. IF: 4.31 

• Kajol; Yadav, V.; Reang, J.; Sharma, K.; Tonk, K. R.; Jain, P.; Verma, S., Overview of the Current Advancements and Trends in the Transungual Drug Delivery System. Letters in Drug Design & Discovery 2023, 20, 1-1. IF: 1.11 

• Suri, R.; Nag, T. C.; Mehra, N.; Neupane, Y. R.; Shafi, S.; Sharma, D.; Sharma, K.; Sultana, Y.; Kohli, K., Sirolimus loaded chitosan functionalized PLGA nanoparticles protect against sodium iodate-induced retinal degeneration. Journal of Drug Delivery Science and Technology 2023, 82, 104369. IF: 5.07 

• Reang, J.; Sharma, K.; Sharma, P. C.; Yadav, V.; Sharma, V.; Majeed, J., Discovery of VEGFR inhibitors through virtual screening and energy assessment. Journal of Biochemical and Molecular Toxicology n/a (n/a), e23321. IF: 3.56 

• Hassan, N.; Farooq, U.; Das, A. K.; Sharma, K.; Mirza, M. A.; Fatima, S.; Singh, O.; Ansari, M. J.; Ali, A.; Iqbal, Z., In Silico Guided Nanoformulation Strategy for Circumvention of Candida albicans Biofilm for Effective Therapy of Candidal Vulvovaginitis. ACS Omega 2023. IF: 4.13 

• Karande, S.; Sharma, K.; Kumar, A.; Charan, S.; Patil, C.; Sharma, A., Potential role of biopeptides in the treatment of idiopathic pulmonary fibrosis. Health Sciences Review 2023, 6, 100081. IF: 1.12 

• Kumar, V.; Sharma, K.; Sachan, R.; Alhayyani, S.; Al-abbasi, F. A.; Singh, R.; Anwar, F., Co-drug development of gallic acid and metformin targeting the pro-inflammatory cytokines for the treatment of breast cancer. Journal of Biochemical and Molecular Toxicology n/a (n/a), e23300. IF: 3.56 

• Ramzan, F.; Nabi, S. A.; Lone, M. S.; Imtiyaz, K.; Urooj, L.; Vishakha, V.; Sharma, K.; Rizvi, M. M. A.; Shafi, S.; Samim, M.; Bano, S.; Javed, K., Synthesis, Molecular Docking, and Biological Evaluation of a New Series of Benzothiazinones and Their Benzothiazinyl Acetate Derivatives as Anticancer Agents against MCF-7 Human Breast Cancer Cells and as Anti-Inflammatory Agents. ACS Omega 2023. IF: 4.13 

• Sharma, S.; Ansari, M. H. R.; Sharma, K.; Singh, R. K.; Ali, S.; Alam, M. M.; Zaman, M. S.; Alam, P.; Akhter, M., Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents. Future Medicinal Chemistry 2023, 15 (1), 9-24. IF: 4.76 

• Spratt, A. N.; Kannan, S. R.; Sharma, K.; Sachdev, S.; Kandasamy, S. L.; Sönnerborg, A.; Lorson, C. L.; Singh, K., Continued Complexity of Mutations in Omicron Sublineages. Biomedicines 2022, 10 (10), 2593. IF: 4.75 

• Arya, P.; Bhandari, U.; Sharma, K.; Bansal, P., Anti-PCSK9 monoclonal antibody attenuates high-fat diet and zymosan-induced vascular inflammation in C57BL/6 mice by modulating TLR2/NF-ƙB signaling pathway. Iranian Journal of Basic Medical Sciences 2022, 25 (5), 577-585. IF: 2.69 

• Gupta, M.; Sharma, V.; Sharma, K.; Kumar, A.; Sharma, A.; Kazmi, I.; Al-Abbasi, F. A.; Alzarea, S. I.; Afzal, O.; Altamimi, A. S. A.; Singh, S. K.; Gupta, G.; Paudel, K. R.; Hansbro, P. M.; Dua, K., A kNGR Peptide-Tethered Lipid&ndash;Polymer Hybrid Nanocarrier-Based Synergistic Approach for Effective Tumor Therapy: Development, Characterization, Ex-Vivo, and In-Vivo Assessment. Pharmaceutics 2022, 14 (7), 1401. IF: 6.526 

• Yadav, V.; Reang, J.; Sharma, V.; Majeed, J.; Sharma, P. C.; Sharma, K.; Giri, N.; Kumar, A.; Tonk, R. K., Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review. Chemical Biology & Drug Design 2022, 100 (3), 389-418. IF: 2.87 

• Aasim; Sharma, R.; Patil, C. R.; Kumar, A.; Sharma, K., Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches. In Silico Pharmacology 2022, 10 (1), 12. IF: 2.12 

• Khan I, Tantray MA, Hamid H, Sarwar Alam M, Sharma K, Kesharwani P. Design, synthesis, in vitro antiproliferative evaluation and GSK-3β kinase inhibition of a new series of pyrimidin-4-one based amide conjugates. Bioorganic Chemistry. 2021 2021/11/26/:105512. IF: 5.275 

• Saathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma, Ramesh Goyal, Anders Sön-nerborg, Subbu Apparsundaram, Christian L. Lorson, Siddappa N. Byrareddy and Kamal Singh., Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions. International Journal of Molecular Science. 2022, 23. IF: 5.946 

• Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies. Journal of Autoimmunity. 2022 2022/01/01/; 126:102779. IF: 14.56 

• Acharya, A.; Pandey, K.; Thurman, M.; Klug, E.; Trivedi, J.; Sharma, K.; Lorson, C. L.; Singh, K.; Byrareddy, S. N.; Gallagher, T., Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants. Journal of Virology 2021, 95 (24), e01437-21. IF: 4.50 

• Naaz, F.; Ahmad, F.; Lone, B. A.; Khan, A.; Sharma, K.; IntzarAli; ShaharYar, M.; Pokharel, Y. R.; Shafi, S., Apoptosis Inducing 1,3,4-Oxadiazole Conjugates of Capsaicin: Their In Vitro Antiproliferative and In Silico Studies. ACS Medicinal Chemistry Letters 2021, 12 (11), 1694-1702. IF: 4.34 

• Kumar, V.; Sachan, R.; Rahman, M.; Rub, R. A.; Patel, D. K.; Sharma, K.; Gahtori, P.; Al-abbasi, F. A.; Alhayyani, S.; Anwar, F.; Kim, H. S., Chemopreventive effects of Melastoma malabathricum L. extract in mammary tumor model via inhibition of oxidative stress and inflammatory cytokines. Biomedicine & Pharmacotherapy 2021, 137, 111298. IF: 7.50 

• Bansal, P.; Bhandari, U.; Sharma, K.; Arya, P., Embelin modulates metabolic endotoxemia and associated obesity in high fat diet fed C57BL/6 mice. Human & Experimental Toxicology 2021, 40 (1), 60-70. IF: 2.80 

• Kumar, V.; Sachan, R.; Rahman, M.; Sharma, K.; Al-Abbasi, F. A.; Anwar, F., Prunus amygdalus extract exert antidiabetic effect via inhibition of DPP-IV: in-silico and in-vivo approaches. Journal of Biomolecular Structure and Dynamics 2021, 39 (11), 4160-4174. IF: 5.23 

• P Ayash Kumar, S. D., Sradhanjali Mohapatra, Saumya Priya Basu, Kalicharan Sharma, Monika Sharma, Aniruddh Pratap Singh, Molecular modeling, synthesis, and evaluation of 1-(4-methoxybenzofuran-5-yl)-3-phenylpropane-1, 3-dione for its anxiolytic potentiality. Issue: 8: 2020; Vol. Volume: 10, p 139-144. IF:0.28 

• Goyal, R. K.; Majeed, J.; Tonk, R.; Dhobi, M.; Patel, B.; Sharma, K.; Apparsundaram, S., Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection. RCM 2020, 21 (3), 365-384. IF: 2.70 

• Sharma, K.; Neshat, N.; Sharma, S.; Giri, N.; Srivastava, A.; Almalki, F.; Saifullah, K.; Alam, M. M.; Shaquiquzzaman, M.; Akhter, M., Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques. Archiv der Pharmazie 2020, 353 (2), 1900287. IF: 5.10 

• Rahman, M.; Al-Ghamdi, S. A.; Alharbi, K. S.; Beg, S.; Sharma, K.; Anwar, F.; Al-Abbasi, F. A.; Kumar, V., Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. Drug Delivery 2019, 26 (1), 782-793. IF: 6.10 

• Mohapatra, S.; Asfer, M.; Anwar, M.; Sharma, K.; Akhter, M.; Ahmad, F. J.; Siddiqui, A. A., Doxorubicin loaded carboxymethyl Assam bora rice starch coated superparamagnetic iron oxide nanoparticles as potential antitumor cargo. Heliyon 2019, 5 (6). IF: 4.01 

• Hassan, N.; Singh, M.; Sulaiman, S.; Jain, P.; Sharma, K.; Nandy, S.; Dudeja, M.; Ali, A.; Iqbal, Z., Molecular Docking-Guided Ungual Drug-Delivery Design for Amelioration of Onychomycosis. ACS Omega 2019, 4 (5), 9583-9592. IF: 4.10 

• Sharma, K.; Tanwar, O.; Deora, G. S.; Ali, S.; Alam, M. M.; Zaman, M. S.; Krishna, V. S.; Sriram, D.; Akhter, M., Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents. Bioorganic & medicinal chemistry 2019, 27 (7), 1421-1429. IF: 3.50 

• Pratap, S.; Naaz, F.; Reddy, S.; Jha, K. K.; Sharma, K.; Sahal, D.; Akhter, M.; Nayakanti, D.; Kumar, H. M. S.; , V.; Pandey, K.; Shafi, S., Anti-proliferative and anti-malarial activities of spiroisoxazoline analogues of artemisinin. Archiv der Pharmazie 2019, 352 (1), 1800192. IF: 5.10 

• Pathak, A.; Rohilla, A.; Gupta, T.; Akhtar, M. J.; Haider, M. R.; Sharma, K.; Haider, K.; Yar, M. S., DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective. European Journal of Medicinal Chemistry 2018, 158, 559-592. IF: 6.70 

• Iqubal, A.; Sharma, S.; Sharma, K.; Bhavsar, A.; Hussain, I.; Iqubal, M. K.; Kumar, R., Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction. Life Sciences 2018, 211, 172-181. IF: 6.10 

• Sharma, K.; Tanwar, O.; Sharma, S.; Ali, S.; Alam, M. M.; Zaman, M. S.; Akhter, M., Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents. Bioorganic Chemistry 2018, 80, 319-333. IF: 5.10 

• Sharma, K.; Srivastava, A.; Tiwari, P.; Sharma, S.; Shaquiquzzaman, M.; Alam, M. M.; Akhter, M., 3D QSAR Based Virtual Screening of Pyrido[1,2-a] Benzimidazoles as Potent Antimalarial Agents. Letters in Drug Design & Discovery 2019, 16 (3), 301-312. IF: 1.10 

• Kumar, V.; Sharma, K.; Ahmed, B.; Al-Abbasi, F. A.; Anwar, F.; Verma, A., Deconvoluting the dual hypoglycemic effect of wedelolactone isolated from Wedelia calendulacea: investigation via experimental validation and molecular docking. RSC Advances 2018, 8 (32), 18180-18196. IF: 3.90 

• Sharma, K.; Shrivastava, A.; Mehra, R. N.; Deora, G. S.; Alam, M. M.; Zaman, M. S.; Akhter, M., Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition. Archiv der Pharmazie 2018, 351 (1), 1700251. IF: 5.10 

• Ranjan, C.; Kumar, J.; Sharma, K.; Akhter, M.; Siddiqui, A. A.; Chawla, G., 1, 2, 4-Oxadiazole Incorporated Ketoprofen Analogues in Search of Safer Non-steroidal Anti-inflammatory Agents: Design, Syntheses, Biological Evaluation and Molecular Docking Studies. Letters in Drug Design & Discovery 2018, 15 (6), 590-601. IF: 1.10 

• Kumar, V.; Bhatt, P. C.; Sharma, K.; Rahman, M.; Patel, D. K.; Sethi, N.; Kumar, A.; Sachan, N. K.; Kaithwas, G.; Al-abbasi, F. A.; Anwar, F.; Verma, A., Melastoma malabathricum Linn attenuates complete freund’s adjuvant-induced chronic inflammation in Wistar rats via inflammation response. BMC Complementary Medicine and Therapies 2016, 16 (1), 510. IF: 4.13 

• Shafi, S.; Afrin, F.; Islamuddin, M.; Chouhan, G.; Ali, I.; Naaz, F.; Sharma, K.; Zaman, M. S., β-Nitrostyrenes as Potential Anti-leishmanial Agents. Frontiers in Microbiology 2016, 7. IF: 5.20 

• Ismail, T.; Shafi, S.; Singh, S.; Sidiq, T.; Khajuria, A.; Rouf, A.; Yadav, M.; Saikam, V.; Singh, P. P.; Alam, M. S.; Islam, N.; Sharma, K.; Kumar, H. M. S., Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins. European Journal of Medicinal Chemistry 2016, 123, 90-104. IF: 6.70 

• Yaseen, R.; Pushpalatha, H.; Reddy, G. B.; Ismael, A.; Ahmed, A.; Dheyaa, A.; Ovais, S.; Rathore, P.; Samim, M.; Akthar, M.; Sharma, K.; Shafi, S.; Singh, S.; Javed, K., Design and synthesis of pyridazinone-substituted benzenesulphonylurea derivatives as anti-hyperglycaemic agents and inhibitors of aldose reductase – an enzyme embroiled in diabetic complications. Journal of Enzyme Inhibition and Medicinal Chemistry 2016, 31 (6), 1415-1427. IF: 5.60 

• Tantray, M. A.; Khan, I.; Hamid, H.; Alam, M. S.; Umar, S.; Ali, Y.; Sharma, K.; Hussain, F., Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3β Inhibitors with Anti-inflammatory Potential. Chemical Biology & Drug Design 2016, 87 (6), 918-926. IF: 3.0 

• Hameed, A. D.; Ovais, S.; Yaseen, R.; Rathore, P.; Samim, M.; Singh, S.; Sharma, K.; Akhtar, M.; Javed, K., Synthesis and Biological Evaluation of New Phthalazinone Derivatives as Anti-Inflammatory and Anti-Proliferative Agents. Archiv der Pharmazie 2016, 349 (2), 150-159. IF: 5.10 

• Akhter, M.; Sharma, K.; Alam, M. M.; Zaman, M. S.; Husain, A.; Ali, S.; A. Khan, S., Structure Assessment Analysis of Core Domain of Seven Protein Data Bank Entries of HIV-1 Protease Using Different in-silico Techniques. Current Enzyme Inhibition 2014, 10 (2), 98-104. IF: 0.21